Selective cyclooxygenase 2 inhibitor induces indefinite survival of fully allogeneic cardiac grafts and generates CD4+ regulatory cells
- 31 October 2005
- journal article
- Published by Elsevier BV in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 130 (4), 1167-1174
- https://doi.org/10.1016/j.jtcvs.2005.06.031
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- EXPRESSION OF CYCLOOXYGENASE-2 IN BIOPSIES OBTAINED FROM HUMAN TRANSPLANTED KIDNEYS UNDERGOING REJECTIONTransplantation, 2003
- The effect of selective inhibition of cyclooxygenase (COX)-2 on acute cardiac allograft rejectionTransplantation, 2002
- Alloantigen–induced specific immunological unresponsivenessPhilosophical Transactions Of The Royal Society B-Biological Sciences, 2001
- COX-2 inhibitorsThe Lancet, 1999
- CYCLOOXYGENASES 1 AND 2Annual Review of Pharmacology and Toxicology, 1998
- Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's diseaseNeurology, 1996
- Selective inhibition of NS-398 on prostanoid production in inflamed tissue in rat carrageenan-air-pouch inflammationJournal of Pharmacy and Pharmacology, 1993
- Measurement of cell proliferation by enzyme‐linked immunosorbent assay (ELISA) using a monoclonal antibody to bromodeoxyuridineCell Proliferation, 1991
- Prostaglandin E2 inhibits in vitro and in vivo lymphocyte responses in allogeneic transplantationThe Annals of Thoracic Surgery, 1990
- PROLONGATION OF RAT CARDIAC ALLOGRAFT SURVIVAL BY THEATMENT WITH PROSTACYCLIN OR ASPIRIN DURING ACUTE REJECTIONTransplantation, 1983